Michael Merges

1.1k total citations
16 papers, 947 citations indexed

About

Michael Merges is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Michael Merges has authored 16 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 8 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Michael Merges's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Michael Merges is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Michael Merges collaborates with scholars based in United States, United Kingdom and Germany. Michael Merges's co-authors include John L. Spouge, Peter L. Nara, Scott P. Layne, Micah Dembo, S Conley, John P. Moore, Jawahar L. Raina, Herbert Renz, Hans R. Gelderblom and A Bossie and has published in prestigious journals such as Nature, Blood and Journal of Virology.

In The Last Decade

Michael Merges

15 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Merges United States 9 727 404 355 193 187 16 947
Ji Zhou China 14 678 0.9× 338 0.8× 578 1.6× 234 1.2× 257 1.4× 22 1.1k
Bert J. M. Al Netherlands 7 896 1.2× 444 1.1× 605 1.7× 231 1.2× 111 0.6× 9 1.1k
Michael Tuen United States 17 488 0.7× 219 0.5× 469 1.3× 134 0.7× 163 0.9× 33 773
Michael D. Moore United States 17 536 0.7× 289 0.7× 453 1.3× 288 1.5× 427 2.3× 22 1.2k
Josef Köstler Germany 14 448 0.6× 347 0.9× 215 0.6× 208 1.1× 278 1.5× 24 958
Réjean Cantin Canada 17 960 1.3× 370 0.9× 815 2.3× 247 1.3× 487 2.6× 25 1.5k
Flavia Ferrantelli Italy 21 585 0.8× 345 0.9× 428 1.2× 200 1.0× 574 3.1× 46 1.2k
Elias K. Halvas United States 15 998 1.4× 850 2.1× 169 0.5× 204 1.1× 205 1.1× 31 1.2k
Alberto Clivio Italy 15 319 0.4× 157 0.4× 367 1.0× 129 0.7× 126 0.7× 30 720
Babak Banapour United States 12 1.2k 1.7× 644 1.6× 639 1.8× 404 2.1× 267 1.4× 14 1.5k

Countries citing papers authored by Michael Merges

Since Specialization
Citations

This map shows the geographic impact of Michael Merges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Merges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Merges more than expected).

Fields of papers citing papers by Michael Merges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Merges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Merges. The network helps show where Michael Merges may publish in the future.

Co-authorship network of co-authors of Michael Merges

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Merges. A scholar is included among the top collaborators of Michael Merges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Merges. Michael Merges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Vargas, Frederick Arce, Claire Roddie, Paul Shaughnessy, et al.. (2022). Industrialization of an Academic Miltenyi Prodigy-Based CAR T Process. Transplantation and Cellular Therapy. 28(3). S201–S202. 1 indexed citations
3.
Vargas, Frederick Arce, Claire Roddie, Paul Shaughnessy, et al.. (2021). Industrialization of an Academic Miltenyi Prodigy-Based CAR T Process. Blood. 138(Supplement 1). 477–477.
4.
Merges, Michael, et al.. (2009). CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures. Cytotechnology. 59(1). 31–44. 103 indexed citations
5.
Pal, Ranajit, James S. Foulke, Ruth Woodward, et al.. (2003). Characterization of a Simian Human Immunodeficiency Virus Encoding the Envelope Gene from the CCR5-Tropic HIV-1 Ba-L. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(3). 300–307. 35 indexed citations
6.
Skurnick, Joan, Paul Palumbo, Anthony L. DeVico, et al.. (2002). Correlates of Nontransmission in US Women at High Risk of Human Immunodeficiency Virus Type 1 Infection through Sexual Exposure. The Journal of Infectious Diseases. 185(4). 428–438. 54 indexed citations
7.
Tsai, Wen-Po, Michael Merges, S Conley, et al.. (1997). Preliminary Findings of an in Vitro Human Spleen Mononuclear Cell Culture System for Primary Isolates of HIV Type 1. AIDS Research and Human Retroviruses. 13(11). 967–977. 3 indexed citations
8.
Spouge, John L., et al.. (1996). A cytopathic infectivity assay of human immunodeficiency virus type 1 in human primary macrophages. Journal of Virological Methods. 59(1-2). 45–55. 8 indexed citations
9.
Wu, Suh‐Chin, John L. Spouge, S Conley, et al.. (1995). Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophages. Journal of Virology. 69(10). 6054–6062. 28 indexed citations
10.
Layne, Scott P., Michael Merges, Micah Dembo, et al.. (1992). Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology. 189(2). 695–714. 275 indexed citations
11.
Layne, Scott P., Michael Merges, John L. Spouge, Micah Dembo, & Peter L. Nara. (1991). Blocking of human immunodeficiency virus infection depends on cell density and viral stock age. Journal of Virology. 65(6). 3293–3300. 52 indexed citations
12.
Merges, Michael & Judith A. Whittum‐Hudson. (1990). In vitro susceptibility of newborn murine retinal cells to herpes simplex virus type 1 infection.. PubMed. 31(7). 1224–30. 3 indexed citations
13.
Layne, Scott P., Michael Merges, Micah Dembo, John L. Spouge, & Peter L. Nara. (1990). HIV requires multiple gp120 molecules for CD4-mediated infection. Nature. 346(6281). 277–279. 162 indexed citations
14.
Nara, Peter L., Linda Smit, Nancy M. Dunlop, et al.. (1990). Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. Journal of Virology. 64(8). 3779–3791. 200 indexed citations
15.
Nara, Peter L., Linda Smit, Nancy M. Dunlop, et al.. (1990). Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.. PubMed. 72. 315–41. 16 indexed citations
16.
Whittum‐Hudson, Judith A., Michael Merges, & Hugh J. Field. (1987). Immunogenicity versus pathogenicity after anterior chamber inoculation of an acyclovir-induced double mutant of HSV-1. Current Eye Research. 6(12). 1459–1470. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026